Building on our solid operations in Europe, we are committed to creating a strong and sustainable clinical research infrastructure and bringing world-class health research skills and clinical trial execution to Africa
Our Brand Promise
We help advance health
through data excellence
- We specialise in public health, clinical and epidemiological research.
- We have a strong track record of collaborating with both private and public partners globally.
- We contribute to the collection, management and reporting of robust and reliable data that impact people’s lives around the world.
See below to learn more about our new identity.
Our identity
Our Solutions

Interventional Studies
Planning and execution of your early stage trials to ensure timely completion of your clinical development programmes.

Capacity Building

Observational Studies

Implementation Research
Recent Blog Posts
Senegal Leads the Way: First Francophone African Country to Achieve WHO Maturity Level 3!
We are thrilled to celebrate a significant achievement in global health and pharmaceutical innovation: Senegal has become the first Francophone country – and seventh country - in Africa to attain Maturity Level 3 (ML3) certification from the World Health Organization...
Strengthening Partnerships: LEAP Africa and Mastercard Foundation Visit Pharmalys
In November 2024, Pharmalys had the pleasure of welcoming representatives from LEAP Africa, the Central Partner of the Mastercard Foundation, to our offices in Dakar, Senegal. The visit provided an opportunity for the representatives to meet with the Pharmalys Academy...
Improving Patient Understanding in Informed Consent: A Need for Action
Obtaining clinical informed consent is both an ethical and legal requirement before invasive medical or surgical procedures. In research, informed consent must be sought and secured before enrolling a participant in a study. The concept of informed consent is founded...